L. Fechter

Enkurin: A novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens

J. Zehnder, A. Krishnan, H. Maecker, 2023, bioRxiv.

Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms

J. Zehnder, A. Krishnan, H. Maecker, 2021, Cell reports. Medicine.

Platelet transcriptome yields progressive markers in chronic myeloproliferative neoplasms and identifies putative targets of therapy

J. Zehnder, A. Krishnan, H. Maecker, 2021, bioRxiv.

FDA-Approved Ruxolitinib in Patients with Myelofibrosis: the Stanford Experience

J. Gotlib, A. Linder, C. Perkins, 2012 .

Enkurin: a novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens

J. Zehnder, A. Krishnan, H. Maecker, 2023, Blood advances.